直接菌根菌体生长抑制试验的开发和应用:一个系统性审查
Hannah Painter1, Eli Harriss2, Helen A Fletcher1
1Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Frontiers in immunology
|February 21, 2024
概括
直接菌根生长抑制试验 (MGIA) 是评估结核病药物和疫苗的宝贵工具. 本综述详细介绍了其20年来的应用和进展,强调了其在了解结核病免疫力方面的实用性.
科学领域:
- 结核病的研究研究.
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 直接菌根菌体生长抑制试验 (MGIA) 于2001年开发,用于评估结核病 (TB) 药物.
- 它测量了宿主免疫力,细菌毒性和干预效应.
- 在过去的13年里,努力集中在将MGIA适应结核病疫苗上,包括优化,协调和验证.
研究的目的:
- 从2001年到2023年6月,系统地审查有关直接MGIA开发和应用的文献.
- 提供关于测试进展的全面更新,并批判性地评估其实用性.
- 确定MGIA研究未来方向的优先事项.
主要方法:
- 进行了对主要出版文献的系统审查.
- 该审查遵循了PRISMA报告准则.
- 文献搜索涵盖了2001年至2023年6月期间.
主要成果:
- 63项研究在各种应用中使用了直接MGIA.
- 应用包括评估结核病药物,疫苗候选物和伴随性疾病的临床队列.
- 该测试有助于理解免疫对抗结核病保护的相关因子.
结论:
- 直接的MGIA在过去二十年中取得了显著的进步.
- 需要进一步的标准化和验证.
- MGIA是对结核病干预措施的早期评估和了解菌根菌控制机制的潜在有价值的工具.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.6K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.2K
相关概念视频
Microbial Growth Measurement: Direct Methods
Direct methods for measuring microbial populations in a culture are essential tools in microbiology, providing quantitative data for various applications. Among these, microscopic counts, plate counts, and serial dilution are widely used techniques, each with unique principles and applications.Microscopic CountsMicroscopic counting involves the use of a Petroff-Hausser chamber, a specialized microscope slide with a grid and defined depth. By observing a liquid culture under a microscope,...
Methods for Controlling Microbial Growth
Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
